Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study

2011197 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov NCT00848692.

Good health and well-being

Published in: PLoS ONE

Volume 6, Issue 10, pp. e26358-e26358

Field-Weighted Citation Impact: 8.00